vs
Side-by-side financial comparison of Ares Commercial Real Estate Corp (ACRE) and Foghorn Therapeutics Inc. (FHTX). Click either name above to swap in a different company.
Ares Commercial Real Estate Corp is the larger business by last-quarter revenue ($13.2M vs $9.2M, roughly 1.4× Foghorn Therapeutics Inc.). Ares Commercial Real Estate Corp runs the higher net margin — -29.2% vs -234.3%, a 205.0% gap on every dollar of revenue. On growth, Foghorn Therapeutics Inc. posted the faster year-over-year revenue change (223.8% vs -24.5%). Over the past eight quarters, Foghorn Therapeutics Inc.'s revenue compounded faster (35.3% CAGR vs -15.9%).
Ares Commercial Real Estate Corp is a specialty finance company focused on the commercial real estate sector. It offers a full suite of customized financing solutions including senior mortgage loans, subordinated debt and preferred equity, primarily serving middle-market commercial property owners and operators across the United States.
Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.
ACRE vs FHTX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.2M | $9.2M |
| Net Profit | $-3.9M | $-21.7M |
| Gross Margin | — | — |
| Operating Margin | -29.2% | -258.2% |
| Net Margin | -29.2% | -234.3% |
| Revenue YoY | -24.5% | 223.8% |
| Net Profit YoY | 63.8% | -11.1% |
| EPS (diluted) | — | $-0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.2M | $9.2M | ||
| Q3 25 | $14.1M | $8.2M | ||
| Q2 25 | $12.6M | $7.6M | ||
| Q1 25 | $14.9M | $6.0M | ||
| Q4 24 | $17.5M | $2.9M | ||
| Q3 24 | $16.7M | $7.8M | ||
| Q2 24 | $16.8M | $6.9M | ||
| Q1 24 | $18.7M | $5.0M |
| Q4 25 | $-3.9M | $-21.7M | ||
| Q3 25 | $4.7M | $-15.8M | ||
| Q2 25 | $-11.0M | $-17.9M | ||
| Q1 25 | $9.3M | $-18.8M | ||
| Q4 24 | $-10.7M | $-19.5M | ||
| Q3 24 | $-5.9M | $-19.1M | ||
| Q2 24 | $-6.1M | $-23.0M | ||
| Q1 24 | $-12.3M | $-25.0M |
| Q4 25 | -29.2% | -258.2% | ||
| Q3 25 | 33.0% | -226.9% | ||
| Q2 25 | -87.8% | -279.2% | ||
| Q1 25 | 64.4% | -385.0% | ||
| Q4 24 | -61.0% | -840.5% | ||
| Q3 24 | -35.3% | -305.5% | ||
| Q2 24 | -36.5% | -386.6% | ||
| Q1 24 | -65.9% | -558.3% |
| Q4 25 | -29.2% | -234.3% | ||
| Q3 25 | 33.0% | -194.4% | ||
| Q2 25 | -87.8% | -237.3% | ||
| Q1 25 | 62.5% | -316.4% | ||
| Q4 24 | -60.9% | -682.9% | ||
| Q3 24 | -35.3% | -244.9% | ||
| Q2 24 | -36.5% | -333.6% | ||
| Q1 24 | -65.9% | -495.4% |
| Q4 25 | — | $-0.35 | ||
| Q3 25 | — | $-0.25 | ||
| Q2 25 | — | $-0.28 | ||
| Q1 25 | — | $-0.30 | ||
| Q4 24 | — | $-0.23 | ||
| Q3 24 | — | $-0.31 | ||
| Q2 24 | — | $-0.45 | ||
| Q1 24 | — | $-0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $29.3M | $80.9M |
| Total DebtLower is stronger | $948.2M | — |
| Stockholders' EquityBook value | $509.6M | $-108.5M |
| Total Assets | $1.6B | $198.1M |
| Debt / EquityLower = less leverage | 1.86× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $29.3M | $80.9M | ||
| Q3 25 | $84.9M | $89.3M | ||
| Q2 25 | $90.0M | $72.6M | ||
| Q1 25 | $125.5M | $61.0M | ||
| Q4 24 | $63.8M | $55.5M | ||
| Q3 24 | $68.9M | $57.7M | ||
| Q2 24 | $70.6M | $138.9M | ||
| Q1 24 | $99.5M | $79.3M |
| Q4 25 | $948.2M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $718.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $509.6M | $-108.5M | ||
| Q3 25 | $521.0M | $-89.7M | ||
| Q2 25 | $523.7M | $-76.7M | ||
| Q1 25 | $542.1M | $-61.7M | ||
| Q4 24 | $540.1M | $-45.5M | ||
| Q3 24 | $563.8M | $-28.3M | ||
| Q2 24 | $582.3M | $-14.3M | ||
| Q1 24 | $601.1M | $-97.5M |
| Q4 25 | $1.6B | $198.1M | ||
| Q3 25 | $1.4B | $205.0M | ||
| Q2 25 | $1.4B | $226.2M | ||
| Q1 25 | $1.5B | $258.7M | ||
| Q4 24 | $1.8B | $284.0M | ||
| Q3 24 | $1.9B | $308.4M | ||
| Q2 24 | $2.1B | $328.6M | ||
| Q1 24 | $2.1B | $255.0M |
| Q4 25 | 1.86× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.33× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $21.4M | $-22.3M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $21.4M | $-22.3M | ||
| Q3 25 | $3.8M | $-18.9M | ||
| Q2 25 | $4.9M | $-21.0M | ||
| Q1 25 | $8.0M | $-24.0M | ||
| Q4 24 | $35.5M | $-24.5M | ||
| Q3 24 | $8.4M | $-21.0M | ||
| Q2 24 | $8.7M | $-25.5M | ||
| Q1 24 | $11.4M | $-29.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-21.0M | ||
| Q1 25 | — | $-24.0M | ||
| Q4 24 | — | $-25.0M | ||
| Q3 24 | — | $-21.3M | ||
| Q2 24 | — | $-25.6M | ||
| Q1 24 | — | $-29.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -278.2% | ||
| Q1 25 | — | -403.2% | ||
| Q4 24 | — | -875.3% | ||
| Q3 24 | — | -273.0% | ||
| Q2 24 | — | -371.0% | ||
| Q1 24 | — | -583.1% |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | — | 16.8% | ||
| Q3 24 | — | 4.0% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 2.0% |
| Q4 25 | — | — | ||
| Q3 25 | 0.82× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.86× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
